학술논문
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial
Document Type
Article
Author
Kennedy, Glen A; Varelias, Antiopi; Vuckovic, Slavica; Le Texier, Laetitia; Gartlan, Kate H; Zhang, Ping; Thomas, Gethin; Anderson, Lisa; Boyle, Glen; Cloonan, Nicole; Leach, Justine; Sturgeon, Elise; Avery, Judy; Olver, Stuart D; Lor, Mary; Misra, Ashish K; Hutchins, Cheryl; Morton, A James; Durrant, Simon TS; Subramoniapillai, Elango; Butler, Jason P; Curley, Cameron I; MacDonald, Kelli P A; Tey, Siok-Keen; Hill, Geoffrey R
Source
In The Lancet Oncology December 2014 15(13):1451-1459
Subject
Language
ISSN
1470-2045